Sample SOAP Note for Inpatient Detoxification from Alcohol with PTSD
Subjective
- Patient reports heavy alcohol consumption (specify amount/frequency) for past [X] years with increased consumption in recent months 1
- Reports multiple failed attempts to quit drinking independently 1
- Endorses withdrawal symptoms when attempting to stop drinking including tremors, anxiety, insomnia, and diaphoresis 2
- Reports traumatic event(s) (specify nature if disclosed) occurring [timeframe] 1
- Describes PTSD symptoms including intrusive thoughts, nightmares about trauma, hypervigilance, avoidance behaviors, and emotional numbness 1, 3
- Patient acknowledges using alcohol to cope with PTSD symptoms, particularly to avoid trauma reminders and manage anxiety 4, 5
- Reports sleep disturbances including difficulty falling asleep, frequent nighttime awakenings, and trauma-related nightmares 1
- Denies current suicidal/homicidal ideation, but reports periods of hopelessness
Objective
- Vital signs: BP [value], HR [value], RR [value], Temp [value], O2 sat [value]
- CIWA-Ar score: [value] (indicating moderate/severe withdrawal requiring medication) 2
- AUDIT score: [value] (scores >9 predict clinically meaningful withdrawal symptoms) 2
- PCL-5 score: [value] (indicating severity of PTSD symptoms) 4
- Physical exam findings: [note tremors, diaphoresis, tachycardia, or other relevant findings]
- Laboratory results:
- CBC: [relevant findings]
- CMP: [relevant findings, especially liver function tests]
- BAC: [value] mg/dL
- Urine toxicology: [results]
Assessment
- Alcohol Use Disorder, severe (DSM-5 criteria met) with physiological dependence requiring medical detoxification 1
- Alcohol withdrawal, [mild/moderate/severe] based on CIWA-Ar score 2
- Post-Traumatic Stress Disorder (DSM-5 criteria met) 1, 3
- Co-occurring PTSD and AUD with evidence that patient uses alcohol specifically to cope with PTSD avoidance symptoms 4, 5
- [Any other relevant medical or psychiatric diagnoses]
Plan
Alcohol Detoxification Protocol
Benzodiazepine regimen for alcohol withdrawal management using symptom-triggered approach with CIWA-Ar monitoring every 1-2 hours 1
- Medication: [Lorazepam/Diazepam/Chlordiazepoxide] [dose] [frequency] based on CIWA-Ar scores
- Taper schedule over [5-7] days as withdrawal symptoms resolve
Supportive care:
PTSD Treatment Plan
Initiate evidence-based psychotherapy for PTSD once patient is medically stable, with priority given to Prolonged Exposure, Cognitive Processing Therapy, or Eye Movement Desensitization and Reprocessing 1, 3
Consider pharmacotherapy for PTSD:
Specific interventions for trauma-related nightmares:
Maintenance of Alcohol Abstinence
Initiate acamprosate (666mg TID) once withdrawal symptoms have resolved to maintain abstinence 1
- Evidence shows acamprosate is the most effective medication for maintaining abstinence with moderate certainty 1
Consider naltrexone as an alternative or in combination with acamprosate for patients with high risk of relapse 1
Psychosocial interventions: